Neuraxis (NRXS) Cost of Revenue (2022 - 2025)
Neuraxis (NRXS) has disclosed Cost of Revenue for 4 consecutive years, with -$1.1 million as the latest value for Q4 2025.
- Quarterly Cost of Revenue fell 1177.02% to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$88293.0 through Dec 2025, down 115.2% year-over-year, with the annual reading at $562916.0 for FY2025, 55.5% up from the prior year.
- Cost of Revenue hit -$1.1 million in Q4 2025 for Neuraxis, down from $762548.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $762548.0 in Q3 2025 to a low of -$1.1 million in Q4 2025.
- Historically, Cost of Revenue has averaged $58851.1 across 4 years, with a median of $78791.0 in 2023.
- Biggest five-year swings in Cost of Revenue: skyrocketed 427.21% in 2024 and later tumbled 1177.02% in 2025.
- Year by year, Cost of Revenue stood at -$47832.0 in 2022, then skyrocketed by 209.58% to $52412.0 in 2023, then soared by 100.44% to $105053.0 in 2024, then crashed by 1177.02% to -$1.1 million in 2025.
- Business Quant data shows Cost of Revenue for NRXS at -$1.1 million in Q4 2025, $762548.0 in Q3 2025, and $146643.0 in Q2 2025.